medical equipment supplier Becton Dickinson and Co will acquire C R Bard Inc, in a $24 billion cash-and-stock deal, adding Bard's devices to its portfolio in the high-growth sectors of oncology and surgery, both companies said on Sunday.
The deal comes two years after Becton Dickinson acquired CareFusion Corp for $12 billion.
"We are confident that this combination will deliver meaningful benefits for customers and patients, as we see opportunities to leverage Becton Dickinson's leadership, especially in medication management and infection prevention," Bard Chief Executive Officer Tim Ring said in a statement.
Becton Dickinson, based in Franklin Lakes, New Jersey, said it expected the acquisition to boost non-U.S.
"We expect that this deal will cause others in the space to take a step back and ask themselves if there is an opportunity to do another large transaction and should we be acting upon it," Forlenza said.